Hospitals may restrict Lilly’s COVID-19 antibody because of limited supply

Published November 17, 2020 2:59pm ET



Hospitals may limit the use of a new Eli Lilly’s antibody treatment that would help COVID-19 patients at risk for serious illness.

The decision comes as hospitals continue dealing with a jump in patients due to spikes in the virus, while managing a tight supply pool. This week, the United States hit 11 million confirmed cases of COVID-19. Nearly 250,000 people have died from the virus.

Already a print subscriber? Click here to login/register your account

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.